Wang Bin, Zhou Fang-Jian, Han Hui, Qin Zi-Ke, Liu Zhou-Wei, Yu Shao-Long
Department of Urology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P. R. China.
Ai Zheng. 2005 Feb;24(2):229-31.
BACKGROUND & OBJECTIVE: Although total cystectomy plus neobladder is widely used, with good outcome, to treat men patients with invasive bladder cancer, the experience of treating women patients with the same therapy is limit. This study was designed to investigate the outcome of total cystectomy plus sigmoid neobladder for women patients with invasive bladder cancer.
Clinical data of 8 women with invasive bladder cancer, who underwent total cystectomy plus sigmoid neobladder from Jan. 2002 to Oct. 2003 in Cancer Center of Sun Yat-sen University, were retrospectively analyzed.
The operations were technically successful in all cases. The mean follow-up was 18 months (ranged 6-24 months). Six patients survived disease-freely;2 developed pelvic metastasis 6 and 12 months after operation respectively. All patients could actively urinate, 4 were continent day and night, 4 were continent at daytime with mild nocturnal incontinence. Mild hydronephrosis was detected in 1 patient 3 months after operation, which disappeared spontaneously 3 months later. Renal function and serum electrolytes were normal in all cases.
Total cystectomy plus sigmoid neobladder could manage invasive bladder cancer in women patients, and the new bladders function well. But night continence in women patients is not as good as that in men patients.
尽管全膀胱切除术加新膀胱术被广泛应用于治疗男性浸润性膀胱癌患者,且效果良好,但采用相同治疗方法治疗女性患者的经验有限。本研究旨在探讨全膀胱切除术加乙状结肠新膀胱术治疗女性浸润性膀胱癌患者的疗效。
回顾性分析2002年1月至2003年10月在中山大学肿瘤防治中心接受全膀胱切除术加乙状结肠新膀胱术的8例女性浸润性膀胱癌患者的临床资料。
所有病例手术技术均获成功。平均随访时间为18个月(6 - 24个月)。6例患者无病生存;2例分别于术后6个月和12个月发生盆腔转移。所有患者均能自主排尿,4例日夜均能控尿,4例白天能控尿但夜间有轻度尿失禁。1例患者术后3个月发现轻度肾积水,3个月后自行消失。所有病例肾功能及血清电解质均正常。
全膀胱切除术加乙状结肠新膀胱术可有效治疗女性浸润性膀胱癌患者,新膀胱功能良好。但女性患者的夜间控尿能力不如男性患者。